CMPX
COMPASS THERAPEUTICS INCData as of 2026 Q2 (06-30) · 13F snapshot
Summary
COMPASS THERAPEUTICS INC (CMPX) is held as common stock by 4 tracked hedge-fund managers, with a combined reported value of ~$19.84M; the largest are Izzy Englander, Ken Griffin, Steven Cohen. 1 tracked manager also disclosed PUT or CALL positions, reported separately below. This quarter: 1 new, 3 added. Data as of 2026 Q2, from public SEC 13F filings, delayed up to ~45 days.
Attention · MediumThis quarter · Heating up
Common-stock holders41 also report options
Congress trades0
Price$1.10vs quarter-end-49.77%
Sectors0
This quarter's moves
Top holderNew1
Added3
Trimmed / sold0
Common-stock positions
PUT and CALL disclosures are excluded from these holder counts and values.
| Investor | Value | % of portfolio | Action |
|---|
PUT / CALL disclosures
Reported separately: 13F option values are not common-stock ownership and do not reveal the full strategy or economic exposure.
Value $161.6K— of portfolio73,8002026 Q2
Value $143.4K— of portfolio65,5002026 Q2
| Investor | Value | % of portfolio | Action |
|---|---|---|---|
| Ken GriffinCALL | $161.6K | — | — |
| Ken GriffinPUT | $143.4K | — | — |
Public SEC 13F filings may appear up to 45 days after quarter-end; STOCK Act / OGE trade filings are generally due within 45 days but may be late. Partial data only — research, not investment advice.